We are an all-Italian pharmaceutical CDMO, founded around content, the constant focal point of everything we do: liquid (such as solutions, suspension and microemulsion), gel and lyophilized pharmaceuticals, medical devices and cosmetics, both for human and veterinary uses and especially for ophthalmic but also for nasal, oral, respiratory, dermatological, otological and diagnostic applications.
Our clients are multinationals and large groups but also small-medium sized pharmaceutical and cosmetics companies.
With decades of experience in the ophthalmic and respiratory sectors, we boast 2 companies: C.O.C. Farmaceutici and Tubilux Pharma.
Our leading-edge technologies, widespread know-how and distinctive values make Content Group a sound pharmaceutical group specialising in contract development & manufacturing and contract filling.
With turnover of 73,2 million Euro in 2020, we are one of Europe’s most acknowledged ophthalmic groups, with customers worldwide and significant growth prospects in Europe, the Middle East, North Africa and the USA -thanks to FDA approval of one of the three production facilities-.
open projects in 2020
Why choose Content Group
From idea to finished product
From development to packaging, by way of production and filling: step by step, we transform an idea into a ready-to-sell pharmaceutical, medical device or cosmetic.
Quality and safety
Products and processes must deliver exceptional quality and safety; this is not simply a goal but our modus operandi, the unflinching daily pursuit of what we believe in.
Dialogue and service
Quality of relationships is fundamental for quality of service. Careful listening to customers’ needs is essential for the rapid delivery of convenient solutions.
Private Label products
An extensive portfolio of safe, effective and technologically advanced products, packaged in single-dose, multi-dose containers, also without preservatives and polyfoil tubes.
State-of-the-art filling technologies
We are equipped with the most modern filling technologies in both sterile and non-sterile environment, and we can handle the most diverse types of packaging: innovative monodose and multidose containers, also in preservative-free versions, and plastic, polyfoil and aluminium tubes.
We guarantee the highest quality standards of containers as well as of products, thanks to direct collaborations with the world’s leading producers of primary packaging.
Tubilux Pharma was established at Naples with the name Tubilux and they pioneered the ophthalmology industry in Italy at that time
Tubilux Pharma joined the Allergan group, becoming not just a local business reality, but an international one.
COC Farmaceutici is founded in Sant’Agata Bolognese with the company name Chemical Organic Compound (hence the acronym C.O.C.). Lameplast, a leader in the production of single-dose and multi-dose packaging in plastic for the pharmaceutical and cosmetics industry, has a stake in the company.
Tubilux Pharma is taken over through a management buy-out allowing it a definite improvement and giving it a more and more prominent position on the Italian and international market.
COC Farmaceutici establishes a second plant in Rovereto (Modena), for the production of cosmetics and personal care and hygiene products. It is a period of great momentum, characterised by significant investments in research and specialisation in various spheres of activity.
Lameplast acquires 100% of COC Farmaceutici.
COC Farmaceutici obtains certification ISO13485 for Medical Devices.
A management setting and reorganization has led to an implementation and localization of our business activity.
Work begins at Rovereto on the construction of COC Farmaceutici's new plant for sterile product processing.
An earthquake strikes the low plain of Modena and Bologna in May, causing extensive damage to both COC Farmaceutici plants, which are nonetheless quickly made safe and fully renovated.
COC Farmaceutici obtains certification to ISO 22716 for our cosmetics division, which changes name to COC Farmaceutici, Health & Beauty division.
Tubilux Pharma has started the qualification process of its manufacturing plant for the approval by FDA with the aim to expand its business to the US market
COC Farmaceutici is taken over, together with Lameplast, by the private equity fund Aksìa Group SGR. This is a decisive step for ensuring continued growth on the global market, projecting the Group’s vision and founding values into the future.
Aksìa Group SGR sells Lameplast while retaining COC Farmaceutici, which continues to specialise in contract manufacturing, filling and packaging of pharmaceutical products, medical devices and products for personal care and hygiene.
Tubilux Pharma is FDA approved
COC Farmaceutici acquires Tubilux Pharma, giving birth to one single CDMO
Birth of Content Group, the commercial entity gathering COC Farmacetuici and Tubilux Pharma
We want to help our partners preserve the health and well-being of patients with products that are safe, top quality, innovative, sustainable - in a word, products of excellence. Such goals entail the creation of long-term win-win partnership; a positive social, economic and environmental commitment; technological and scientific innovation; staff participation to improve continuously and to achieve our objectives.
We are an all-Italian pharmaceutical CDMO, an acronym that says what we do (contract development and manufacturing organization) without saying who does it: all of us, who work day in, day out as a team to build not just the future of Content Group, but our own future too. The clients who entrust part of their business to us rely on each and every one of us, on our personal and professional abilities and our loyalty. We have always known this, and so we act accordingly, inspired by these values:
- Excellence. A lofty but not unachievable goal, which informs our approach day in, day out: a way of working that sees us focus unflinchingly on the quality and safety of every product and every company process.
- Respect. No client is just a client. We believe in sharing not just goals, but the responsibilities that striving to achieve them entails.
- Ethics and fairness. We are fair competitors on the market, because we believe in the quality of our products and services, and the skills of our employees and associates. In any contractual relationship that implies a form of hierarchy, authority is exercised fairly and ethically, with no tolerance of abuse.
- Protection of Intellectual Property Rights. We consider these a most valuable asset, to protect and respect at all times. Because ideas have always been the real driver of progress.
- People and Talent. We strive never to lose sight of individuals, never to hide them behind the pretext of a professional relationship or reduce them to a mere role or job description.
- Sustainability. We want to grow, but we want to do so responsibly, in a way that respects the environment, our employees and our clients. Only this way can we succeed in consolidating in the long term the achievements made thus far.
The conduct of everyone who works for or with Content Group complies with a clearly defined style, which over time has helped to shape and consolidate our corporate culture.
We base all professional and personal relationships on loyalty, in the knowledge that giving and deserving trust are two sides of the same coin.
To be considered trustworthy we must put ourselves in the shoes of those who have put their faith in us. Often this means even going above and beyond mere duty, for the sake of a mutually beneficial collaboration.
In our relations with the various stakeholders we avoid all discrimination on the basis of age, gender, sexual orientation, health, ethnicity, nationality, political opinions and religious beliefs.
Within our organisation, we share information, knowledge, goals and areas for improvement without reservations of any kind. We act without ulterior motives, in the certain belief that the only interests worth pursuing are those of Content Group.
Single-dose, multi-dose, bottles and other formats
We propose various types of primary containers: